An independent replication of park16 in asian samples

C. Vilariño-Güell; O. A. Ross; J. O. Aasly; L. R. White; A. Rajput; A. H. Rajput; T. Lynch; A. Krygowska-Wajs; B. Jasinska-Myga; G. Opala; M. Barcikowska; M. C. Lee; F. Hentati; R. J. Uitti; Z. K. Wszolek; M. J. Farrer; R. M. Wu

doi:10.1212/WNL.0b013e318202031f

An independent replication of park16 in asian samples

C. Vilariño-Güell, O. A. Ross, J. O. Aasly, L. R. White, A. Rajput, A. H. Rajput, T. Lynch, A. Krygowska-Wajs, B. Jasinska-Myga, G. Opala, M. Barcikowska, M. C. Lee, F. Hentati, R. J. Uitti, Z. K. Wszolek, M. J. Farrer, R. M. Wu

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	2248-2249
Number of pages	2
Journal	Neurology
Volume	75
Issue number	24
DOIs	https://doi.org/10.1212/WNL.0b013e318202031f
State	Published - Dec 14 2010

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e318202031f

Cite this

Vilariño-Güell, C., Ross, O. A., Aasly, J. O., White, L. R., Rajput, A., Rajput, A. H., Lynch, T., Krygowska-Wajs, A., Jasinska-Myga, B., Opala, G., Barcikowska, M., Lee, M. C., Hentati, F., Uitti, R. J., Wszolek, Z. K., Farrer, M. J., & Wu, R. M. (2010). An independent replication of park16 in asian samples. Neurology, 75(24), 2248-2249. https://doi.org/10.1212/WNL.0b013e318202031f

An independent replication of park16 in asian samples. / Vilariño-Güell, C.; Ross, O. A.; Aasly, J. O.; White, L. R.; Rajput, A.; Rajput, A. H.; Lynch, T.; Krygowska-Wajs, A.; Jasinska-Myga, B.; Opala, G.; Barcikowska, M.; Lee, M. C.; Hentati, F.; Uitti, R. J.; Wszolek, Z. K.; Farrer, M. J.; Wu, R. M.

In: Neurology, Vol. 75, No. 24, 14.12.2010, p. 2248-2249.

Research output: Contribution to journal › Article › peer-review

Vilariño-Güell, C. ; Ross, O. A. ; Aasly, J. O. ; White, L. R. ; Rajput, A. ; Rajput, A. H. ; Lynch, T. ; Krygowska-Wajs, A. ; Jasinska-Myga, B. ; Opala, G. ; Barcikowska, M. ; Lee, M. C. ; Hentati, F. ; Uitti, R. J. ; Wszolek, Z. K. ; Farrer, M. J. ; Wu, R. M. / An independent replication of park16 in asian samples. In: Neurology. 2010 ; Vol. 75, No. 24. pp. 2248-2249.

@article{0b8e1e9da1404984912747c337001790,

title = "An independent replication of park16 in asian samples",

author = "C. Vilari{\~n}o-G{\"u}ell and Ross, {O. A.} and Aasly, {J. O.} and White, {L. R.} and A. Rajput and Rajput, {A. H.} and T. Lynch and A. Krygowska-Wajs and B. Jasinska-Myga and G. Opala and M. Barcikowska and Lee, {M. C.} and F. Hentati and Uitti, {R. J.} and Wszolek, {Z. K.} and Farrer, {M. J.} and Wu, {R. M.}",

note = "Funding Information: Study funding: Supported by NIH NINDS P50 NS40256 and the Michael J. Fox Foundation. Funding Information: Disclosure: Dr. Vilarino-Guell reports no disclosures. Dr. Ross serves on the editorial board of Open Longevity Science. Dr. Aasly serves on the editorial boards of Parkinsonism & Related Disorders, Tidsskrift Norske L{\ae}geforening , and Parkinson Disease ; and is coauthor on a patent re: LRRK2 G2019S. Dr. White reports no disclosures. Dr. Alex Rajput has served on scientific advisory boards for Novartis and UCB; has received funding for travel and speaker honoraria from Novartis; serves on the editorial board of the Canadian Journal of Neurological Sciences ; and has received research support from Novartis, Allergan Inc., the NIH (NINDS U01 NS050324-01A1 [local PI]) , CIHR, International Essential Tremor Foundation, Regina Curling Classic for Parkinson's research, and Parkinson's disease and movement disorders endowment through RUH Foundation. Dr. Ali Rajput receives research support from the Saskatchewan Parkinson's Disease Foundation, Curling Classic, and PrintWest Golf Classic. Dr. Lynch serves/has served on scientific advisory boards for Merck Serono, the UK Parkinson's Disease Association, the Dublin Neurological Institute at the Mater Misericordiae University Hospital, the Irish Institute of Clinical Neuroscience, and Neuroscience Ireland; has received speaker honoraria from Lundbeck Inc. and Boehringer Ingelheim; and has received unrestricted educational grants from Orion Corporation, Lundbeck Inc., Boehringer Ingelheim, Bayer Schering Pharma, Biogen Idec, and GlaxoSmithKline for opening of the Dublin Neurological Institute, Ireland. Dr. Krygowska-Wajs reports no disclosures. Dr. Jasinska-Myga has received research support from the Robert and Clarice Smith Fellowship Program, the Pacific Alzheimer Research Foundation, and the Polish Foundation for Development of Neurology, Degenerative and Cerebrovascular Diseases. Dr. Opala serves on the editorial board of Neurologia i Neurochirurgia Polska, Polski Przegl{\c a}d Neurologiczny, Neurologia po Dyplomie , and Psychogeriatria Polska. Dr. Barcikowska has received speaker honoraria from Novartis. Dr. Lee and Dr. Hentati report no disclosures. Dr. Uitti serves as an Associate Editor of Neurology {\textregistered}; has received research support from Advanced Neuromodulations Systems and the NIH/NINDS (P50NS 40256 [coinvestigator]) ; and his institution receives annual royalties from Lundbeck Inc. from the licensing of the technology related to PARK8/LRRK2 . Dr. Wszolek serves as Co-Editor-in-Chief of Parkinsonism and Related Disorders , Regional Editor of the European Journal of Neurology , and on the editorial boards of Neurologia i Neurochirurgia Polska, Advances in Rehabilitation , the Medical Journal of the Rzeszow University , and Clinical and Experimental Medical Letters ; holds and has contractual rights for receipt of future royalty payments from patents re: A novel polynucleotide involved in heritable Parkinson's disease; receives royalties from publishing Parkinsonism and Related Disorders (Elsevier, 2007, 2008, 2009) and the European Journal of Neurology (Wiley-Blackwell, 2007, 2008, 2009) ; receives research support from Allergan, Inc., the NIH (NIA P01AG017216-1 [coinvestigator], NIA R01AG015866-1 [coinvestigator], and NINDS P50NS 40256 [coinvestigator]) , the Pacific Alzheimer Research Foundation (Canada), and the CIHR. Dr. Farrer serves on a scientific advisory board for the Michael J. Fox Foundation; serves/has served on the editorial boards of Neurobiology of Disease and Parkinsonism and Related Disorders ; is coinventor on patents re: LRRK2 gene and mutations; receives institutional research support from Lundbeck Inc.; has received research support from the NIH (NS40256 [Project and Core PI]) , the Pacific Alzheimer Research Foundation, and the Michael J. Fox Foundation; and his institution receives annual royalties from Lundbeck Inc. from the licensing of the technology related to PARK8/LRRK2 . Dr. Wu reports no disclosures. Clinical/Scientific Notes ",

year = "2010",

month = dec,

day = "14",

doi = "10.1212/WNL.0b013e318202031f",

language = "English (US)",

volume = "75",

pages = "2248--2249",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "24",

}

TY - JOUR

T1 - An independent replication of park16 in asian samples

AU - Vilariño-Güell, C.

AU - Ross, O. A.

AU - Aasly, J. O.

AU - White, L. R.

AU - Rajput, A.

AU - Rajput, A. H.

AU - Lynch, T.

AU - Krygowska-Wajs, A.

AU - Jasinska-Myga, B.

AU - Opala, G.

AU - Barcikowska, M.

AU - Lee, M. C.

AU - Hentati, F.

AU - Uitti, R. J.

AU - Wszolek, Z. K.

AU - Farrer, M. J.

AU - Wu, R. M.

N1 - Funding Information: Study funding: Supported by NIH NINDS P50 NS40256 and the Michael J. Fox Foundation. Funding Information: Disclosure: Dr. Vilarino-Guell reports no disclosures. Dr. Ross serves on the editorial board of Open Longevity Science. Dr. Aasly serves on the editorial boards of Parkinsonism & Related Disorders, Tidsskrift Norske Lægeforening , and Parkinson Disease ; and is coauthor on a patent re: LRRK2 G2019S. Dr. White reports no disclosures. Dr. Alex Rajput has served on scientific advisory boards for Novartis and UCB; has received funding for travel and speaker honoraria from Novartis; serves on the editorial board of the Canadian Journal of Neurological Sciences ; and has received research support from Novartis, Allergan Inc., the NIH (NINDS U01 NS050324-01A1 [local PI]) , CIHR, International Essential Tremor Foundation, Regina Curling Classic for Parkinson's research, and Parkinson's disease and movement disorders endowment through RUH Foundation. Dr. Ali Rajput receives research support from the Saskatchewan Parkinson's Disease Foundation, Curling Classic, and PrintWest Golf Classic. Dr. Lynch serves/has served on scientific advisory boards for Merck Serono, the UK Parkinson's Disease Association, the Dublin Neurological Institute at the Mater Misericordiae University Hospital, the Irish Institute of Clinical Neuroscience, and Neuroscience Ireland; has received speaker honoraria from Lundbeck Inc. and Boehringer Ingelheim; and has received unrestricted educational grants from Orion Corporation, Lundbeck Inc., Boehringer Ingelheim, Bayer Schering Pharma, Biogen Idec, and GlaxoSmithKline for opening of the Dublin Neurological Institute, Ireland. Dr. Krygowska-Wajs reports no disclosures. Dr. Jasinska-Myga has received research support from the Robert and Clarice Smith Fellowship Program, the Pacific Alzheimer Research Foundation, and the Polish Foundation for Development of Neurology, Degenerative and Cerebrovascular Diseases. Dr. Opala serves on the editorial board of Neurologia i Neurochirurgia Polska, Polski Przegląd Neurologiczny, Neurologia po Dyplomie , and Psychogeriatria Polska. Dr. Barcikowska has received speaker honoraria from Novartis. Dr. Lee and Dr. Hentati report no disclosures. Dr. Uitti serves as an Associate Editor of Neurology ®; has received research support from Advanced Neuromodulations Systems and the NIH/NINDS (P50NS 40256 [coinvestigator]) ; and his institution receives annual royalties from Lundbeck Inc. from the licensing of the technology related to PARK8/LRRK2 . Dr. Wszolek serves as Co-Editor-in-Chief of Parkinsonism and Related Disorders , Regional Editor of the European Journal of Neurology , and on the editorial boards of Neurologia i Neurochirurgia Polska, Advances in Rehabilitation , the Medical Journal of the Rzeszow University , and Clinical and Experimental Medical Letters ; holds and has contractual rights for receipt of future royalty payments from patents re: A novel polynucleotide involved in heritable Parkinson's disease; receives royalties from publishing Parkinsonism and Related Disorders (Elsevier, 2007, 2008, 2009) and the European Journal of Neurology (Wiley-Blackwell, 2007, 2008, 2009) ; receives research support from Allergan, Inc., the NIH (NIA P01AG017216-1 [coinvestigator], NIA R01AG015866-1 [coinvestigator], and NINDS P50NS 40256 [coinvestigator]) , the Pacific Alzheimer Research Foundation (Canada), and the CIHR. Dr. Farrer serves on a scientific advisory board for the Michael J. Fox Foundation; serves/has served on the editorial boards of Neurobiology of Disease and Parkinsonism and Related Disorders ; is coinventor on patents re: LRRK2 gene and mutations; receives institutional research support from Lundbeck Inc.; has received research support from the NIH (NS40256 [Project and Core PI]) , the Pacific Alzheimer Research Foundation, and the Michael J. Fox Foundation; and his institution receives annual royalties from Lundbeck Inc. from the licensing of the technology related to PARK8/LRRK2 . Dr. Wu reports no disclosures. Clinical/Scientific Notes

PY - 2010/12/14

Y1 - 2010/12/14

UR - http://www.scopus.com/inward/record.url?scp=78650846243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650846243&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e318202031f

DO - 10.1212/WNL.0b013e318202031f

M3 - Article

C2 - 21172849

AN - SCOPUS:78650846243

VL - 75

SP - 2248

EP - 2249

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 24

ER -